Clinical Trial Update: A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002) [Phase 1]

View source ↗

Summary

Phase 1 study of an investigational heat-treated V212 varicella-zoster vaccine in immunocompromised adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Herpes Zoster-related Complications

Drugs mentioned

• V212/Heat-Treated Varicella-Zoster Virus Vaccine (V212)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster, Herpes Zoster-related Complications | Phase 1 | Status: COMPLETED | Results posted: 2019-04-16